Topic: TAKEDA
46 results were found.
Takeda operating profit down 56.4% - May 10, 2024
Takeda licenses Hutchmed cancer drug for manufacture outside China region - January 23, 2023
Japan's Takeda to buy Nimbus' psoriasis drug for psoriasis - December 14, 2022
Takeda Q1 CER core revenue growth 8.3% - August 1, 2022
Takeda and Moderna to transfer marketing authorization for Spikevax COVID vaccine in Japan to Moderna - May 31, 2022
Takeda reports robust free cash flow - May 11, 2022
Takeda suspends new clinical trials in Russia - April 11, 2022
Takeda says human error caused contamination of Moderna vaccines - October 1, 2021
Takeda sells four diabetes products to Teijin Pharma for $1.25 billion - February 26, 2021
CADE conditionally clears acquisition of portfolio of medicines of Takeda by Hypera - January 25, 2021
Takeda completes sale of select non-core assets to Cheplapharm - January 7, 2021
Takeda to sell $2.29 billion Japan consumer health unit valued to Blackstone - August 24, 2020
Commission waives Takeda commitments to obtain clearance of acquisition of Shire - June 1, 2020
Takeda net profit down, revenues climb - May 13, 2020
Takeda to divest select assets in Latin America to Hypera Pharma for $825 million - March 2, 2020
Takeda unveils new dengue vaccine manufacturing plant in Germany - November 10, 2019
Takeda agrees to divest select OTV and non-core assets to Acino for over $200 million - October 15, 2019
Sosei Heptares and Takeda enter into new commercialization partnership - August 5, 2019
Takeda Pharmaceutical FY18 profit down - May 14, 2019
Novartis buys dry eye drug from Takeda for up to $5.3 billion - May 9, 2019
Takeda takes control of Shire - January 8, 2019
Takeda gets shareholder approval for $62bn Shire deal - December 5, 2018
EU clears Takeda's Shire acquisition on divestment condition - November 21, 2018
Takeda's Shire takeover to bring $963 million fee - November 13, 2018
Takeda aims to close $62 billion Shire deal Jan. 8 - November 12, 2018
Takeda in talks with EC, Shire and Entyvio - October 29, 2018
Takeda gets Japan's approval for $62 billion Shire purchase - October 18, 2018
Takeda gets clearance for Shire deal from U.S. FTC - July 10, 2018
Takeda to buy pharma rival Shire in $62 billion deal - May 8, 2018
Shire board 'would be willing' to recommend £46 billion Takeda deal - April 25, 2018
Shire mulling new offer from Takeda - April 24, 2018
Shire rejects $60 billion bid from Takeda - April 19, 2018
Japan's Takeda eyes takeover of Shire - March 29, 2018
Takeda to acquire Ariad Pharmaceuticals in $5.2 billion deal - January 9, 2017
Takeda to consolidate research sites worldwide - August 1, 2016
U.S. judge to Takeda: Hikma Pharma didn't hurt your patents - May 19, 2016
Takeda appoints James Kehoe as new CFO - May 13, 2016
Takeda 3Q underlying revenue growth 3.8% - February 3, 2016
AstraZeneca boosts respiratory unit with $575 million Takeda deal - December 16, 2015
Takeda Pharmaceutical underlying revenue increased 2.8% - May 16, 2015
Takeda settles in the U.S., will pay $2.7 billion - April 29, 2015
Takeda appoints COO - December 2, 2013
Takeda announces appointment of chief financial officer - August 28, 2013
Takeda appoints two executives - June 28, 2010
Honda Siel Cars India: CEO Masahiro Takedagawa to step down - February 22, 2010
Takeda San Francisco: Michael Buckley new vice president - October 12, 2009